On Monday, SI-BONE Inc (NASDAQ: SIBN) was -12.57% drop from the session before settling in for the closing price of $20.44. A 52-week range for SIBN has been $12.49 – $21.89.
Healthcare Sector giant saw their annual sales surged by 13.67% over the last five years. When this article was written, the company’s average yearly earnings per share was at 29.17%. With a float of $38.74 million, this company’s outstanding shares have now reached $43.27 million.
SI-BONE Inc (SIBN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SI-BONE Inc stocks. The insider ownership of SI-BONE Inc is 10.72%, while institutional ownership is 99.18%. The most recent insider transaction that took place on Jan 08 ’26, was worth 425,506. In this transaction Director of this company sold 20,000 shares at a rate of $21.28, taking the stock ownership to the 80,115 shares. Before that another transaction happened on Jan 08 ’26, when Company’s Director proposed sale 60,000 for $21.40, making the entire transaction worth $1,284,000.
SI-BONE Inc (SIBN) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.11 earnings per share (EPS) during the time that was better than consensus figure (set at -0.13) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.86% during the next five years compared to 13.67% growth over the previous five years of trading.
SI-BONE Inc (NASDAQ: SIBN) Trading Performance Indicators
You can see what SI-BONE Inc (SIBN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.49 in one year’s time.
